Other Clinical Trial - Enhanced Outcome Prediction in Cutaneous Squamous

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03291002` - Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC	Phase 1
Not yet recruiting	`NCT03621462` - Elucid Labs AIDA™ - Labelled Image Acquisition Protocol	N/A
Not yet recruiting	`NCT04480645` - CivaDerm(TM) Surface Therapy Pilot Study	Early Phase 1
Recruiting	`NCT03370861` - How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
Recruiting	`NCT06014086` - Intratumoral PH-762 for Cutaneous Carcinoma	Phase 1
Completed	`NCT02347813` - Preventing Squamous Cell Skin Cancer	Phase 2
Terminated	`NCT01984892` - Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)	Phase 2
Completed	`NCT00563290` - Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia	Phase 2
Recruiting	`NCT04204837` - Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin	Phase 2
Completed	`NCT03894618` - SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas	Phase 1
Terminated	`NCT01823679` - Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin	Phase 2
Completed	`NCT00126555` - Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer	Phase 2
Completed	`NCT00089180` - T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant	Phase 2
Not yet recruiting	`NCT05246228` - Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy
Recruiting	`NCT05886140` - Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin	N/A
Completed	`NCT02324608` - Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer	N/A
Recruiting	`NCT02717936` - Investigation of Desmoplastic Squamous Cell Carcinoma	N/A
Recruiting	`NCT05482880` - Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
Withdrawn	`NCT01465815` - Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)	Phase 1/Phase 2
Recruiting	`NCT05490485` - Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma	Phase 2

NCT number	NCT06327971
Study type	Observational
Source	Queen Mary University of London
Contact
Status	Active, not recruiting
Phase
Start date	October 20, 2023
Completion date	October 2028

Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms